BioScrip

BioScrip® is a leading provider in comprehensive, cost-effective pharmaceutical and home care solutions. Our goal is to partner with patients, physicians, healthcare payors, government agencies and pharmaceutical manufacturers to provide access to infusible medications and management solutions that optimize outcomes for chronic and other complex healthcare conditions. At BioScrip, our patients receive personalized, safe, effective and convenient infusion therapies to help improve quality of life. Our team of professionals assist each patient in every step of their office or home infusion experience.
Type
Public
HQ
Denver, US
Employees
1,844 (est)-5%
BioScrip is headquartered in Denver, US

Key People at BioScrip

Richard M. Smith

Richard M. Smith

President & CEO
Hai Tran

Hai Tran

CFO

BioScrip Locations

Denver, US
Elmsford, US
Eden Prairie, US

BioScrip Metrics

BioScrip Summary

Market capitalization

$154 M

Closing share price

$1.41
BioScrip's current market capitalization is $154 M.

BioScrip Financials

BioScrip's revenue is $982 M in FY, 2015 which is 0.19% decrease from the previous period.
FY, 2013FY, 2014FY, 2015

Revenue

$842 M$984 M$982 M

Gross profit

$272 M$261 M$261 M

Operating income

$-6.97 M$-91.1 M$-288 M

Operating expense total

$166 M

Net Income

$-69.7 M$-147 M$-300 M

Operating cash flow

$-61.1 M$-261 K$14.8 M

    BioScrip Market Value History

    BioScrip Online Presence

    BioScrip News

    BioScrip Company Life

    You may also be interested in